526 related articles for article (PubMed ID: 15049601)
21. Systemic methotrexate therapy for psoriasis: past, present and future.
Dogra S; Mahajan R
Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
[TBL] [Abstract][Full Text] [Related]
22. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
23. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
24. Adverse events from systemic therapies for psoriasis are common in clinical practice.
Pearce DJ; Higgins KB; Stealey KH; Balkrishnan R; Crane MM; Camacho F; Fleischer AB; Feldman SR
J Dermatolog Treat; 2006; 17(5):288-93. PubMed ID: 17092859
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of psoriasis by methotrexate in the era of biotherapies: a study in 21 Tunisian patients].
Khaled A; Ben Hamida M; Zeglaoui F; Kharfi M; Ezzine N; Fazaa B
Therapie; 2012; 67(1):49-52. PubMed ID: 22487502
[TBL] [Abstract][Full Text] [Related]
26. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
Rosenberg P; Urwitz H; Johannesson A; Ros AM; Lindholm J; Kinnman N; Hultcrantz R
J Hepatol; 2007 Jun; 46(6):1111-8. PubMed ID: 17399848
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate and psoriasis: consensus conference.
Kalb RE; Strober B; Weinstein G; Lebwohl M
J Am Acad Dermatol; 2011 Jun; 64(6):1179. PubMed ID: 21571176
[No Abstract] [Full Text] [Related]
28. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
Spuls PI; Tuut MK; van Everdingen JJ; de Rie MA;
Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2121-5. PubMed ID: 15553355
[TBL] [Abstract][Full Text] [Related]
29. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
30. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
Nijsten T; Spuls PI
Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
[No Abstract] [Full Text] [Related]
31. Methotrexate treatment in 13 children with severe plaque psoriasis.
Collin B; Vani A; Ogboli M; Moss C
Clin Exp Dermatol; 2009 Apr; 34(3):295-8. PubMed ID: 19175782
[TBL] [Abstract][Full Text] [Related]
32. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
Eskicirak B; Zemheri E; Cerkezoglu A
Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
[TBL] [Abstract][Full Text] [Related]
33. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
Opmeer BC; Heydendael VM; De Borgie CA; Spuls PI; Bossuyt PM; Bos JD; De Rie MA
Arch Dermatol; 2004 Jun; 140(6):685-90. PubMed ID: 15210458
[TBL] [Abstract][Full Text] [Related]
34. [Acute methotrexate toxicity in psoriasis].
Arévalo-López A
Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
[TBL] [Abstract][Full Text] [Related]
35. [Methotrexate and pregnancy].
Ibsen HH
Ugeskr Laeger; 1997 Oct; 159(41):6081-3. PubMed ID: 9381582
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report.
Kamangar F; Berger TG; Fazel N; Koo JY
Cutis; 2013 Sep; 92(3):148-50. PubMed ID: 24153144
[TBL] [Abstract][Full Text] [Related]
37. Severe vertigo requiring hospitalization whilst taking low-dose oral methotrexate for psoriasis.
Swale VJ; Sahota A
Clin Exp Dermatol; 2005 May; 30(3):295-6. PubMed ID: 15807694
[No Abstract] [Full Text] [Related]
38. Yellow nail pigmentation due to methotrexate.
Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
Dermatology; 1998; 197(3):276. PubMed ID: 9867364
[No Abstract] [Full Text] [Related]
39. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
